DEUTSCHE BANK AG\ - LEXICON PHARMACEUTICALS INC ownership

LEXICON PHARMACEUTICALS INC's ticker is and the CUSIP is 528872AB0. A total of 11 filers reported holding LEXICON PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of LEXICON PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$1,814,000
-10.8%
4,500,0000.0%0.00%
-50.0%
Q1 2020$2,033,000
-34.2%
4,500,0000.0%0.00%0.0%
Q4 2019$3,090,000
+7.2%
4,500,0000.0%0.00%0.0%
Q3 2019$2,882,000
-40.3%
4,500,0000.0%0.00%
-33.3%
Q2 2019$4,825,000
+6.6%
4,500,0000.0%0.00%0.0%
Q1 2019$4,525,000
-9.2%
4,500,0000.0%0.00%
-25.0%
Q4 2018$4,982,000
-62.9%
4,500,000
-50.0%
0.00%0.0%
Q3 2018$13,441,000
-6.5%
9,000,0000.0%0.00%0.0%
Q2 2018$14,382,000
+146.9%
9,000,000
+100.0%
0.00%
+33.3%
Q1 2018$5,826,0004,500,0000.00%
Other shareholders
LEXICON PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 17,500,000$31,512,0006.26%
ANGELO GORDON & CO., L.P. 10,000,000$17,913,0001.32%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 12,000,000$21,586,000,0000.42%
WOLVERINE ASSET MANAGEMENT LLC 8,750,000$15,714,0000.20%
LAZARD ASSET MANAGEMENT LLC 9,570,000$17,190,0000.04%
Citadel Advisors 16,800,000$30,248,0000.03%
UBS ASSET MANAGEMENT AMERICAS LLC 8,000,000$14,305,0000.02%
ClearBridge Investments 3,000,000$5,503,0000.01%
JPMORGAN CHASE & CO 1,880,000$3,449,0000.00%
View complete list of LEXICON PHARMACEUTICALS INC shareholders